| ATAIBECKLEY INC. O.N. |
| USA |
| Gesundheit |
| US04650F1012 / A41WEP |
| B72 (Frankfurt) / ATAI (NASDAQ) |
| FRA:B72, ETR:B72, B72:GR, NASDAQ:ATAI |
| - |
| https://www.ataibeckley.c.. |
|
AtaiBeckley Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative psychedelic-based therapeutics and neuroplastogens to treat mental health disorders. The company was formed through the strategic combination of atai Li..
>Volltext.. |
| 1710.82 Mio. EUR |
| 1513.14 Mio. EUR |
| 3.06 Mio. EUR |
| -111.21 Mio. EUR |
| -582.75 Mio. EUR |
| -1.97 EUR |
| 1.76 Mio. EUR |
| 37.86 Mio. EUR |
| -95.87 Mio. EUR |
| 9.24 |
| 1075.97% |
| -1732.82% |
| - |
| - |
| - |
| ATAIBECKLEY, ATAI BECKLEY |
| 30.06.26 |
|
||||
|
||||
|
||||
|
||||
|